A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects
- 1 June 2000
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (6), 691-699
- https://doi.org/10.1046/j.1365-2036.2000.00772.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- An ascending single‐dose safety and tolerance study of an oral formulation of rabeprazole (E3810)Alimentary Pharmacology & Therapeutics, 1998
- H. pylori eradication reduces the effect of lansoprazole but not that of ranitidine on intragastric pHGastroenterology, 1998
- 2B: H. pylori infection in childhoodGut, 1996
- OmeprazoleDrugs, 1994
- Variability in individual response to various doses of omeprazoleDigestive Diseases and Sciences, 1994
- Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux DiseaseDigestion, 1992
- 24-Hour Intragastric Acidity and Plasma Gastrin during Long-Term Treatment with Omeprazole or Ranitidine in Patients with Reflux EsophagitisScandinavian Journal of Gastroenterology, 1991
- The relationship between suppression of acidity and gastric ulcer healing ratesAlimentary Pharmacology & Therapeutics, 1990
- Royal Free Hospital Protocol for 24-Hour Intragastric Acidity and Plasma Gastrin ConcentrationDigestive Diseases, 1990
- Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.Gut, 1984